Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-23-000007 General Corporate
Debt relative to revenue 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
194.91% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.69% · OPTIONAL · VALID
Operating cash generation 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-14.52% · OPTIONAL · VALID
Revenue growth 95th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
12.76% · CORE · VALID
Inventory pressure 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
83.69% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
35.10% · CORE · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.46% · CORE · VALID
R&D intensity 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.49% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.82% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 213.10%
Current 194.91%
Delta -18.19% Capex Intensity Increased
Previous 1.47%
Current 1.69%
Delta 0.22% Cash Generation Decreased
Previous 15.17%
Current -14.52%
Delta -29.69% Growth Increased
Previous 1.60%
Current 12.76%
Delta 11.16% Inventory Pressure Increased
Previous 79.78%
Current 83.69%
Delta 3.90% Margin Decreased
Previous 36.83%
Current 35.10%
Delta -1.73% Profitability Decreased
Previous 17.06%
Current 12.46%
Delta -4.60% R And D Intensity Increased
Previous 2.76%
Current 3.49%
Delta 0.73% Sbc Intensity Increased
Previous 0.71%
Current 0.82%
Delta 0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.